Cyclacel Pharmaceuticals CYCCP 深沪

已收盘 10-11 16:00:00 美东时间

6.81

-0.680

-9.08%

华盛通

立即下载

最高7.02
今开7.00
成交量 694股
最低 6.81
昨收 7.49
总市值 8170.23万
52周最高 22.20
市盈率 ^静 --
换手率 0.01%
52周最低 5.10
委比 0.00%
总股本 1199.74万
历史最高 22.20
量比 1.10
振幅 2.80%
历史最低 -4.089
每手 1
风险率 4.86%

个股概要

财务分析

公司资料

分红派息

分时图
日k
周k
月k

相关新闻

快讯 | Cyclacel Pharmaceuticals：决议通过，暂停每季度兑换型可转换优先股票的现金股息支付，预计于11月1日

Cyclacel Pharmaceuticals: Passed Resolution to Suspend Qtrly Cash Dividend Paym...

09-07 04:07
Cyclacel files an appeal to Nasdaq delisting letter

Biopharma company Cyclacel Pharmaceuticals (NASDAQ:CYCC) said on Tuesday it has filed an appeal to Nasdaq’s delisting letter and requested a hearing, which has been scheduled for October 15. The reque...

09-03 21:48
Cyclacel Pharmaceuticals GAAP EPS of -$0.72

Cyclacel Pharmaceuticals press release (NASDAQ:CYCC): Q2 GAAP EPS of -$0.72. Revenue of $4,000 (vs. $373K in Q2/2023). As of June 30, 2024, cash equivalents totaled $6M, compared to $3.4M as of Decemb...

08-15 20:55
快讯 | cyclacel pharmaceuticals, inc.现有的现金资源将为计划中的项目提供资金，直至2024年第四季度。

Cyclacel Pharmaceuticals Inc - Current Cash Resources Will Fund Planned Program...

08-15 04:09
快讯 | Cyclacel pharmaceuticals：收到欧洲专利局意向通知，涵盖Plogosertib药品组成的专利即将授权。

Cyclacel Pharmaceuticals: Got Notice From European Patent Office of Intention t...

06-26 21:21
Cyclacel Pharmaceuticals Announces Key Corporate Decisions at 2024 Annual Meeting

Cyclacel Pharmaceuticals (CYCC) has shared an announcement. During Cyclacel Pha...

06-25 18:29
快讯 | Cyclacel Pharmaceuticals：Fadraciclib在2024年ASCO年会上展示了在患者源性结直肠癌模型中的功效。

Cyclacel Pharmaceuticals：Fadraciclib在2024年ASCO年会上展示了在患者源性结直肠癌模型中的功效。

06-04 07:08
快讯 | Cyclacel Pharmaceuticals：fadraciclib在2024年ASCO年会上展示出对患者衍生的结肠癌模型的疗效。

Cyclacel Pharmaceuticals: Fadraciclib Demonstrates Efficacy in Patient-Derived ...

06-04 07:06
Cyclacel Pharmaceuticals files to sell 15.2M shares for holders

Cyclacel Pharmaceuticals (NASDAQ:CYCC) on Monday filed a prospectus related to a proposed resale of about 15.2M shares of its common stock by selling stockholders. This prospectus is not an offer to s...

05-07 05:54
Cyclacel Pharmaceuticals Analyst Ratings

Unity Software(U.US) reported fourth-quarter financial results after the market...

05-03 22:14

派息除权日	每股总股息	派息日期
2024-01-19	0.15	2024-02-01
2023-10-19	0.15	2023-11-01
2023-07-20	0.15	2023-08-01
2023-04-20	0.15	2023-05-01
2023-01-12	0.15	2023-02-01
2022-10-13	0.15	2022-11-01
2022-07-14	0.15	2022-08-01
2022-04-13	0.15	2022-05-01
2022-01-13	0.15	2022-02-01
2021-10-14	0.15	2021-11-01
2021-07-15	0.15	2021-08-01
2021-04-15	0.15	2021-05-01
2021-01-14	0.15	2021-02-01
2020-10-15	0.15	2020-11-01
2020-07-16	0.15	2020-08-01
2020-04-14	0.15	2020-05-01
2020-01-16	0.15	2020-02-01
2019-10-10	0.15	2019-11-01
2019-07-11	0.15	2019-08-01
2019-04-12	0.15	2019-05-01
2019-01-11	0.15	2019-02-01
2018-10-12	0.15	2018-11-01
2018-07-12	0.15	2018-08-01
2018-04-10	0.15	2018-05-01
2018-01-11	0.15	2018-02-01
2017-10-12	0.15	2017-11-01
2017-07-12	0.15	2017-08-01
2017-04-11	0.15	2017-05-01
2017-01-13	0.15	2017-02-01
2016-10-13	0.15	2016-11-01
2016-07-13	0.15	2016-08-01
2016-04-14	0.15	2016-05-01
2016-01-19	0.15	2016-02-01
2015-10-21	0.15	2015-11-02
2015-07-15	0.15	2015-08-03
2015-04-15	0.15	2015-05-01
2014-12-31	0.15	2015-02-02
2014-06-27	0.15	2014-08-01
2014-04-15	0.15	2014-05-01
2014-01-15	0.15	2014-02-03
2013-10-17	0.15	2013-11-01
2013-07-18	0.15	2013-08-01
2013-04-17	0.15	2013-05-01
2013-01-17	0.15	2013-02-01
2011-04-19	0.15	2011-05-02
2011-01-19	0.15	2011-02-01
2009-01-14	0.15	2009-01-30
2008-10-16	0.15	2008-11-01
2008-07-16	0.15	2008-08-01
2008-04-16	0.15	2008-05-01
2008-01-16	0.15	2008-02-01
2007-10-17	0.15	2007-11-01
2007-07-18	0.15	2007-08-01
2007-04-18	0.15	2007-05-01
2007-01-18	0.15	2007-02-01
2006-10-19	0.15	2006-11-01
2006-07-20	0.15	2006-08-01
2006-04-26	0.15	2006-05-01
2006-01-18	0.15	2006-02-01
2005-10-19	0.15	2005-11-01
2005-07-20	0.15	2005-08-01
2005-04-20	0.15	2005-05-02
2005-01-19	0.15	2005-02-01

公司名称	Cyclacel Pharmaceuticals, Inc.
行业分类	Pharmaceuticals: Major
业务描述	Cyclacel Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the provision of cell cycle, transcriptional regulation and DNA damage response biology to develop medicines for cancer and other proliferative diseases. It operates through the United States and United Kingdom geographical segments. The company builds a biopharmaceutical business, which is focused on hematology and oncology based on a pipeline of novel drug candidates. Its products include CYC065, seliciclib, and sapacitabine. The company was founded by Ronald J. Berenson, David Philip Lane, and David Glover on August 13, 1996 and is headquartered in Berkeley Heights, NJ.

Cyclacel Pharmaceuticals CYCCP 深 沪

6.81

个股概要

财务分析

公司资料

相关新闻

分红派息

相关新闻

公司简介

Cyclacel Pharmaceuticals CYCCP 深沪